|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Cash flows from operating activities: | |
| Net income | |
| Adjustments to reconcile net income to net cash provided by operating activities: | |
| Depreciation, depletion, and amortization | |
| Amortization of debt issuance costs | |
| Share-based compensation expense | |
| Loss (gain) on derivative instruments | |
| Cash received on settlement of derivative instruments | |
| Non-cash lease expense | |
| Deferred income taxes | |
| Changes in operating assets and liabilities: | |
| Accounts receivable | |
| Prepaid expenses and other assets | |
| Accounts payable | |
| Royalties payable | |
| Accrued and other expenses | |
| Other assets and liabilities | |
| Net cash provided by operating activities | |
| Cash flows from investing activities: | |
| Additions to oil and gas properties | |
| Deposits of acquisitions of oil and gas properties | |
| Additions to midstream and other property and equipment | |
| Net cash used in investing activities | |
| Cash flows from financing activities: | |
| Borrowings under revolving credit facility | |
| Borrowings on notes payable | |
| Payments on revolving credit facility | |
| Proceeds from issuance of Class A common stock in initial public offering, net of underwriting discounts and commissions | |
| Payments of debt issuance costs | |
| Payments of initial public offering costs | |
| Payments on notes payable | |
| Distributions to noncontrolling interest owners | |
| Share Repurchase Program | |
| Net cash provided by financing activities | |
| Net increase in cash and cash equivalents | |
| Cash and cash equivalents at beginning of period | |
| Cash and cash equivalents at end of period |
Loading...
